ARCHIVES

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

December 9, 1988

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

April 5, 1974

California Weighs Listing Tamoxifen As Carcinogen

October 27, 1995

NSABP Roundup: Fisher, Pitt Negotiating; 9th Chairman Candidate

October 7, 1994